EndoQuest Robotics

EndoQuest Robotics is a leading innovator in the development of transformative endoluminal robotic technologies. The company has pioneered the Endoluminal Surgical (ELS) System, the world's first endoluminal robotic surgical system that makes it possible for therapeutic endoscopists and surgeons to perform upper and lower gastrointestinal surgery less-invasively through a trans-oral or trans-anal approach. EndoQuest's proprietary technology combines the flexibility of conventional endoscopy to navigate the body's curvatures with the precision of traditional surgical techniques. This allows physicians to access target disease sites directly through the body's natural orifices, performing minimally invasive procedures using only internal incisions that do not result in visible scarring.

The ELS System design features a proprietary flexible and steerable endoscope serving as an overtube that supports the use of two surgical instruments and a videoscope. EndoQuest's robotic platform enhances physician control, precision, and efficiency, enabling safer and more effective minimally invasive treatments. The technology holds further potential for applications in various surgeries like appendectomies and cholecystectomies that could be performed without external incisions.

In January 2024, EndoQuest partnered with OMNIVISION to integrate the latter's cutting-edge OCHFA CameraCubeChip into the ELS System's visualization component, offering best-in-class endoscopic imaging capabilities. The company's Flexible Robotic System has also earned a spot in the FDA's Safer Technologies Program (STeP) as of January 2024, ensuring a streamlined development and review process without compromising regulatory standards.

In August 2022, EndoQuest announced the installation of its first ELS System at Brigham and Women's Hospital in Boston, a global leader in endoluminal surgery innovation. This partnership aimed to advance the clinical and procedural development of the technology.